Radiopharmaceutical Therapy Tracker

Mar 30, 2026
Radiopharmaceutical Therapy Tracker logo with purple circular target symbol and text

To help keep up with the dynamic landscape in nuclear medicine fueled by theranostics, AuntMinnie offers the Radiopharmaceutical Therapy (RPT) Tracker. Reach us at [email protected] with new entries or updates.

Last Updated: October 13, 2026 ↓
Latest News: October 13, 2026 ▾
Company Drug (Isotope) / Imaging Agent Indication(s) / Target Stage

 

 

Latest in Nuclear Medicine
Research presentation on nuclear medicine fragmentation showing 25 studies with PET imaging criteria analysis and expert interview
EANM: Is ‘research fragmentation’ holding back nuclear medicine?
October 21, 2026
Explore Innovations at EANM 2026
Sponsored
Explore Innovations at EANM 2026
October 1, 2026
Clinical research presentation slide showing FAP RLT experience data table with patient outcomes across multiple institutions and speaker photo
EANM: Thomas Hope on what’s next in FAP-targeted theranostics
October 19, 2026
Hand holding glowing atom symbol with blue and gold light effects against blurred tech background
Nuclidium, NorthStar sign Cu-67 supply and manufacturing deal
October 19, 2026
Related Stories
Clinical research presentation slide showing FAP RLT experience data table with patient outcomes across multiple institutions and speaker photo
Nuclear Medicine
EANM: Thomas Hope on what’s next in FAP-targeted theranostics
Hand holding glowing atom symbol with blue and gold light effects against blurred tech background
Nuclear Medicine
Nuclidium, NorthStar sign Cu-67 supply and manufacturing deal
3D medical illustration of a human kidney showing internal anatomical structures and blood vessels
Molecular Imaging
Norroy secures FDA breakthrough therapy, fast track status for PET imaging agent
Explore Innovations at EANM 2026
Sponsor Content
Explore Innovations at EANM 2026
More in Nuclear Medicine
EANM: Is ‘research fragmentation’ holding back nuclear medicine?
By Will Morton
Well-designed studies require collaboration among nuclear medicine, medical oncology, urology, radiation oncology, and clinical trial support.
October 21, 2026
Research presentation on nuclear medicine fragmentation showing 25 studies with PET imaging criteria analysis and expert interview
Telix posts revenue growth in Q3
By AuntMinnie.com staff writers
For the period (end-September 30), Telix had group revenues of $245 million, up from $206 million in the same period last year.
October 21, 2026
Business analyst examining financial data charts and percentages through magnifying glass on laptop screen
EANM: Thomas Hope on what’s next in FAP-targeted theranostics
By Will Morton
The innovations and work being done to optimize FAP agents will likely "spill over" to other targets.
October 19, 2026
Clinical research presentation slide showing FAP RLT experience data table with patient outcomes across multiple institutions and speaker photo
Nuclidium, NorthStar sign Cu-67 supply and manufacturing deal
By AuntMinnie.com staff writers
Cu-67 is the therapeutic half of Nuclidium’s theranostic platform, which pairs it with copper-61 (Cu-61) for diagnostic imaging.
October 19, 2026
Hand holding glowing atom symbol with blue and gold light effects against blurred tech background
Capitol Imaging Services acquires Impression Imaging
By AuntMinnie.com staff writers
CIS said the deal is part of its expansion into molecular imaging and theranostics.
October 16, 2026
Two businessmen in suits shaking hands during a professional meeting
AtomVie, Jubilant Radiopharma enter distribution partnership
By AuntMinnie.com staff writers
Jubilant will handle receipt, regulatory compliance, and distribution of AtomVie-manufactured radiopharmaceuticals.
October 15, 2026
Digital handshake with blue and orange technology network patterns symbolizing business partnership and innovation
Nusano, Primo Biotechnology ink isotope supply deal
By AuntMinnie.com staff writers
The agreement will support Primo’s cancer therapy pipeline.
October 14, 2026
Glowing atom symbol with blue and orange energy effects over laboratory equipment and scientific instruments
Lu-177 PNT2002 before SBRT extends disease control in prostate cancer
By Will Morton
A group from the University of California, Los Angeles, updated an analysis of outcomes from the LUNAR trial by 10 months.
October 13, 2026
X-ray scan of pelvis with highlighted prostate gland in red for medical diagnosis
Jubilant to invest 94.5M CAD in manufacturing facility
By AuntMinnie.com staff writers
The investment will double output of the firm's RubyFill rubidium-82 chloride cardiac PET agent.
October 9, 2026
Digital illustration of a glowing human heart with technological and medical monitoring elements integrated into a blue digital interface background.
Nuclidium images first patient in phase II trial of Cu-61 PSMA tracer
By AuntMinnieEurope.com staff writers
The trial will enroll nearly three dozen patients with biopsy-confirmed metastatic prostate cancer at U.S. sites.
October 6, 2026
Nuclidium logo featuring blue atomic symbol with red accent and company name in sans-serif type
GE HealthCare to acquire Sofie Biosciences for $945M
By AuntMinnie.com staff writers
The deal is expected to close in the first half of 2027.
October 5, 2026
Scattered US dollar bills including $100 and $1 denominations arranged in overlapping pattern
Radnostix to sell nuclear fuel processing assets for $13.5M
By AuntMinnie.com staff writers
Assets include a U.S. Nuclear Regulatory Commission (NRC) license, patented technology, and related technical materials.
October 1, 2026
Scientist in lab coat holding glowing atomic symbol representing scientific innovation and research
Page 1 of 446
Next Page